RAP 0.00% 20.5¢ resapp health limited

Ann: Increased Scheme Consideration from Pfizer, page-375

  1. 6,719 Posts.
    lightbulb Created with Sketch. 850
    The Dx would be a genius tool if it could distinguish between upper/lower respiratory and the flu wouldn't it? Something to look forward to after Pfizer lose the vote. We won't outguess Pfizer but the NO vote is a good bet IMHO (odds on?)
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.